Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Todd Schlesinger, Eggert Stockfleth, Ayman Grada & Brian Berman. (2022) Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action. Clinical, Cosmetic and Investigational Dermatology 15, pages 2495-2506.
Read now
Read now
Dnyanesh Saindane, Sankha Bhattacharya, Rahul Shah & Bhupendra G. Prajapati. (2022) The recent development of topical nanoparticles for annihilating skin cancer. All Life 15:1, pages 843-869.
Read now
Read now
Morgan A. Farr, Tejas P. Joshi & Daniel J. Lewis. (2021) Resiquimod: a new topical immune-response modifier for the treatment of actinic keratosis. Expert Opinion on Emerging Drugs 26:4, pages 433-434.
Read now
Read now
Articles from other publishers (20)
Irit Allon, Jacob Pettesh, Alejandro Livoff, Mark Schlapobersky, Oded Nahlieli & Eli Michaeli. (2023) Voltage-Dependent Anion Channel 1 Expression in Oral Malignant and Premalignant Lesions. Diagnostics 13:7, pages 1225.
Crossref
Crossref
Taja Žitek, Dragana Bjelić, Petra Kotnik, Andrej Golle, Staša Jurgec, Uroš Potočnik, Željko Knez, Matjaž Finšgar, Ivan Krajnc, Igor Krajnc & Maša Knez Marevci. (2022) Natural Hemp-Ginger Extract and Its Biological and Therapeutic Efficacy. Molecules 27:22, pages 7694.
Crossref
Crossref
Tatiana Evgenievna Sukhova, Yulia Vladimirovna Molochkova & Anna Igorevna Pronina. (2022) Laser induced thermotherapy of multiple actinic keratosis. Russian Journal of Skin and Venereal Diseases 25:3, pages 181-190.
Crossref
Crossref
Dimitrios Sgouros, Adamantia Milia-Argyti, Dimitrios K. Arvanitis, Eleni Polychronaki, Fiori Kousta, Antonios Panagiotopoulos, Sofia Theotokoglou, Anna Syrmali, Konstantinos Theodoropoulos, Alexander Stratigos, Dimitrios Rigopoulos & Alexander Katoulis. (2022) Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients’ Illness Perceptions. Current Oncology 29:7, pages 5150-5163.
Crossref
Crossref
Jiaqi Zhu, Bernd Gillissen, Dieu Linh Dang Tran, Stefanie May, Claas Ulrich, Eggert Stockfleth & Jürgen Eberle. (2022) Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential. Antioxidants 11:7, pages 1416.
Crossref
Crossref
Laura Del Regno, Silvia Catapano, Alessandro Di Stefani, Simone Cappilli & Ketty Peris. (2022) A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions. American Journal of Clinical Dermatology 23:3, pages 339-352.
Crossref
Crossref
Meital Oren-Shabtai, Nadezhda Sloutsky, Moshe Lapidoth, Daniel Mimouni, Ilia Chorny, Igor Snast, Yael Anne Leshem, Rivka Friedland, Emmilia Hodak, Ifat Klein, Yael Agmon & Assi Levi. (2022) Efficacy and safety of a thermal fractional skin rejuvenation system (Tixel) for the treatment of facial and/or scalp actinic keratoses. Lasers in Medical Science 37:7, pages 2899-2905.
Crossref
Crossref
Diem-Phuong D. Dao, Vikram Nath Sahni, Dev Ram Sahni, Esther A. Balogh, Ayman Grada & Steven R. Feldman. (2021) 1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses. Annals of Pharmacotherapy 56:4, pages 494-500.
Crossref
Crossref
Chan Hu, Xiaojing Liu, Peiru Wang, Lehang Guo, Chunxiao Li, Mingyuan Xu, Guolong Zhang & Xiuli Wang. (2022) Dermoscopy and ultrosound monitoring actinic keratosis with cutaneous squamous cell carcinoma: A case report and literature review. Photodiagnosis and Photodynamic Therapy 37, pages 102709.
Crossref
Crossref
Regina Yavel, J. Scott Overcash, David Cutler, Jane Fang & Jay Zhi. (2021) Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic Keratosis. Clinical Pharmacology in Drug Development 11:3, pages 397-405.
Crossref
Crossref
Y. Gilaberte & M.T. Fernández-Figueras. (2022) [Translated article] Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis. Actas Dermo-Sifiliográficas 113:1, pages T58-T66.
Crossref
Crossref
Y. Gilaberte & M.T. Fernández-Figueras. (2022) Tirbanibulina: revisión de su mecanismo de acción novedoso y de cómo encaja en el tratamiento de la queratosis actínica. Actas Dermo-Sifiliográficas 113:1, pages 58-66.
Crossref
Crossref
Y. Gilaberte & M.T. Fernández-Figueras. (2021) WITHDRAWN: Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis. Actas Dermo-Sifiliográficas (English Edition).
Crossref
Crossref
Ali Sadeghinia, Delara Amir Dastmalchi, Nika Kianfar, Shayan Dasdar, Hamidreza Mahmoudi, Soheila Dabiran, Vahideh Lajevardi & Maryam Daneshpazhooh. (2021) Efficacy and safety of hydrogen peroxide topical solution in treating actinic keratosis: A randomized controlled trial. Dermatologic Therapy 34:5.
Crossref
Crossref
Dorothée Nashan & Linda Maria Mathias. (2021) Aktinische Keratosen: Feste Therapiesequenzen gibt es nicht. Deutsches Ärzteblatt Online.
Crossref
Crossref
Shuo Yuan, Yong-Qiang Luo, Jia-Hui Zuo, Hui Liu, Fang Li & Bin Yu. (2021) New drug approvals for 2020: Synthesis and clinical applications. European Journal of Medicinal Chemistry 215, pages 113284.
Crossref
Crossref
Julia Fromme & Cornelia Mauch. (2021) Diagnostik und Therapie aktinischer Keratosen*. InFo Hämatologie + Onkologie 24:4, pages 41-51.
Crossref
Crossref
Andrew BlauveltSteven KempersEdward LainTodd SchlesingerStephen TyringSeth FormanGlynis AblonGeorge MartinHui WangDavid L. CutlerJane FangMin-Fun R. Kwan. (2021) Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis. New England Journal of Medicine 384:6, pages 512-520.
Crossref
Crossref
Julia Fromme & Cornelia Mauch. (2020) Aktinische Keratosen. CME 17:10, pages 9-19.
Crossref
Crossref
D. Nashan, S. Hüning, M. V. Heppt, A. Brehmer & C. Berking. (2020) Aktinische KeratosenActinic keratoses. Der Hautarzt 71:6, pages 463-475.
Crossref
Crossref